Mass Photometry (MP)

Mass Photometry (MP) is a label-free technique that measures the mass of individual molecules in their native state directly in solution. It works by detecting the light scattered by single molecules as they land on a glass surface. The amount of scattered light is directly proportional to the molecule's mass, essentially allowing the instrument to "weigh" one molecule at a time.

In the field of AAV gene therapy, MP has emerged as a rapid and transformative tool for one of the most critical quality attributes: the AAV full/empty capsid ratio. By precisely measuring the mass of thousands of individual viral capsids in minutes, it can clearly distinguish between capsids containing the therapeutic DNA genome ("full") and those that are empty.

Legacy: The traditional gold standards for measuring the AAV full/empty ratio are Analytical Ultracentrifugation (AUC) and Cryo-Transmission Electron Microscopy (Cryo-TEM). These methods are informative but are also slow, low-throughput, and require large amounts of sample and significant expertise.

Current: MP has emerged as a rapid and widely adopted tool for in-process characterization of the AAV full/empty ratio, increasingly used alongside orthogonal methods such as AUC and Cryo-TEM.

Future: The technology is evolving towards greater robustness for use in GMP/QC environments, along with more advanced data analysis software using AI/ML for automated classification of different AAV species (e.g., full, empty, partially full, aggregated).

MP measures mass based on the principle of interference scattering microscopy.

• Sample Application: A small volume of a highly diluted AAV sample is placed onto a clean glass coverslip in the instrument.
• Detection Event: As individual AAV capsids diffuse in the solution and land on the glass surface, they scatter a small amount of light from an illumination source.
• Contrast Measurement: This scattered light interferes with the much larger amount of light reflected from the glass surface. This interference creates a dark "spot" or "contrast" that is captured by a high-speed camera.
• Mass Correlation: The magnitude of this contrast is directly and linearly proportional to the molecular mass of the particle that landed.
• Histogram Generation: The instrument records thousands of these landing events per minute, measuring the mass of each individual particle. It then plots this data as a mass histogram, showing the distribution of masses in the sample.

• Data Output: A mass histogram showing the number of detected particles (counts) versus their measured molecular mass (in kDa or MDa).
• Interpretation: For an AAV sample, the histogram will show distinct peaks:
• For AAV9, an empty capsid is typically ~3.7 MDa, while a full capsid carrying a ~4.7 kb genome is ~5.3 MDa. Values differ by serotype and genome length.
• Aggregate Peaks: Smaller peaks at integer multiples of the monomer mass (e.g., ~7.4 MDa for an empty dimer).
  The full/empty ratio is calculated from the relative areas under the "full" and "empty" peaks.

• Speed: Extremely fast, with results generated in under 5 minutes per sample.
• Low Sample Consumption: Requires only microliters of sample at nanomolar concentrations.
• Native Analysis: Measures molecules in their native state in solution, without labels or harsh treatments.
• Direct Measurement: Provides a direct mass-based readout of the full/empty ratio and aggregation state.

• Surface landing effects may bias particle representation, particularly for larger aggregates or heterogeneous mixtures.
• Limited Resolution: May not resolve species with very close masses, such as partially filled capsids from empty or full capsids.
• Buffer & Concentration Constraints: Samples must be diluted into a specific concentration range and simple buffers for optimal performance.
• Emerging GMP Application: While powerful for R&D, its use as a validated GMP release test is still evolving.

• Mass Calibration: The instrument must be calibrated using a set of protein standards with well-defined molecular weights (e.g., BSA, Apoferritin).
• System Suitability: A known AAV reference material is often run to ensure the instrument can accurately measure mass and resolve the full and empty peaks.
• Precision & Accuracy: Validation studies must demonstrate that the measured full/empty ratio is repeatable and accurate, often by comparing results to a reference method like AUC.
• Validation should include assessment of linearity across expected particle concentrations and robustness across formulation buffers.

Protein standards are used for routine mass calibration.

AAV reference materials with a full/empty ratio that has been orthogonally characterized (e.g., by AUC or TEM) are essential for method development and ensuring run-to-run consistency.

AAV Gene Therapy: This is the primary and most impactful application of Mass Photometry. It is used to measure the full/empty ratio, aggregation, and purity of AAV vectors for all serotypes.

Other Modalities: The technique is also highly valuable for analyzing aggregation of monoclonal antibodies (mAbs), assembly of protein complexes, and purity of vaccine antigens.